Does RANOLAZINE Cause Nephrolithiasis? 23 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Nephrolithiasis have been filed in association with RANOLAZINE (Ranolazine). This represents 0.2% of all adverse event reports for RANOLAZINE.
23
Reports of Nephrolithiasis with RANOLAZINE
0.2%
of all RANOLAZINE reports
0
Deaths
14
Hospitalizations
How Dangerous Is Nephrolithiasis From RANOLAZINE?
Of the 23 reports, 14 (60.9%) required hospitalization.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANOLAZINE. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does RANOLAZINE Cause?
Death (692)
Myocardial infarction (610)
Stent placement (593)
Chest pain (592)
Angina pectoris (583)
Dizziness (517)
Dyspnoea (348)
Cerebrovascular accident (334)
Fall (299)
Off label use (270)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which RANOLAZINE Alternatives Have Lower Nephrolithiasis Risk?
RANOLAZINE vs RAPAMUNE
RANOLAZINE vs RASAGILINE
RANOLAZINE vs RASBURICASE
RANOLAZINE vs RAVULIZUMAB
RANOLAZINE vs RAVULIZUMAB-CWVZ